POST Online Media Lite Edition



 

Micreos appoints Matt Regan as CEO of its pharmaceutical business

Christian Fernsby |
The Hague, Netherlands - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new pharmaceutical business that will be based in Switzerland.

Article continues below




Mr. Regan joins Micreos with extensive biopharmaceutical experience from almost 3 decades working with Global healthcare leaders including Abbott, Novo Nordisk, and AbbVie.

 LATEST MOVES FROM Netherlands 

Forcyd hires James MacGregor to lead their UK practice
Just Eat Takeaway chairman Adriaan Nühn resigns
Micreos appoints Joost Goderie as CFO and member of the board
CLEVR appoints Michael Winfield as UK MD
Norgine announces senior management changes